Nguyen Hien Minh, Dao Minh Quang
Department of Biochemistry, Thanh Nhan Hospital, Hanoi, Vietnam,
Department of Oncology, Thanh Nhan Hospital, Hanoi, Vietnam.
Breast Cancer (Dove Med Press). 2019 Mar 18;11:143-150. doi: 10.2147/BCTT.S193777. eCollection 2019.
Detecting circulating tumor cells (CTCs) is a promising approach for evaluating the progression of occult metastases as well as the efficacy of treatment therapies among patients with breast cancer. A real-time reverse transcriptase polymerase chain reaction (RT-PCR) technique has been proposed for detecting CTCs due to its high sensitivity. In this study, we aimed to validate the RT-PCR technique for human mammaglobin (hMAM) mRNA detection among Vietnamese women with breast cancer.
Peripheral blood samples and breast cancer tissues from 43 patients suffering from breast cancer and 21 patients with fibroids were obtained. Real-time RT-PCR and gene sequencing techniques were employed to detect gene in CTCs of breast cancer cell lines and cancer tissues.
mRNA transcription was detected in 36 out of 43 (83.7%) breast cancer tissues and in blood of 23 out of 43 (53.5%) breast cancer patients, while it was detected in only 9.5% out of tissues and 0% of the blood of fibrosis patients. mRNA in the peripheral blood of breast cancer patients increased with tumor size, stage of cancer and distant metastasis (<0.05). No difference in the expression of mRNA was found in breast cancer tissue regarding age, distant metastasis, lymph node, stages of cancer and histopathology (>0.05).
The study highlighted the expression of mRNA in breast cancer cells and tissues. This reveals the overall picture of the replication of mRNA in breast cancer, suggesting the role of mRNA in breast cancer molecular pathology.
检测循环肿瘤细胞(CTC)是评估隐匿性转移进展以及乳腺癌患者治疗疗效的一种有前景的方法。由于其高灵敏度,一种实时逆转录聚合酶链反应(RT-PCR)技术已被用于检测CTC。在本研究中,我们旨在验证RT-PCR技术用于检测越南乳腺癌女性患者中人乳腺珠蛋白(hMAM)mRNA的情况。
获取了43例乳腺癌患者和21例子宫肌瘤患者的外周血样本及乳腺癌组织。采用实时RT-PCR和基因测序技术检测乳腺癌细胞系和癌组织的CTC中的基因。
43例乳腺癌组织中有36例(83.7%)检测到mRNA转录,43例乳腺癌患者中有23例(53.5%)的血液中检测到mRNA转录,而在纤维化患者的组织中仅9.5%检测到,血液中未检测到。乳腺癌患者外周血中的mRNA随肿瘤大小、癌症分期和远处转移增加(<0.05)。在乳腺癌组织中,mRNA表达在年龄、远处转移、淋巴结、癌症分期和组织病理学方面无差异(>0.05)。
该研究突出了mRNA在乳腺癌细胞和组织中的表达。这揭示了mRNA在乳腺癌中复制的整体情况,提示mRNA在乳腺癌分子病理学中的作用。